Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

African Regulatory Harmonization Project Cuts Drug Approval Times And Saves Scarce Resources

Executive Summary

A pilot project of joint assessments in East Africa has shown that regulatory review times for a number of branded medicines were reduced from one or two years to a median of seven months, representing a reduction of 40-60%. The project was part of the African Medicines Regulatory Harmonization initiative, which is intended to strengthen and align regulatory practices in sub-Saharan Africa. Part one of this article looks at the history of the AMRH, the 2016 Model Law that guides national regulators in implementing their own procedures, and the East African pilot that has shown joint reviews to be feasible at the regional level.

Advertisement

Related Content

Tanzanian Drugs Regulator Wins WHO Performance Accolade
‘Regulatory Reliance’ Projects Bearing Fruit In Caribbean & Africa
African Countries Adopt Treaty To Set Up New Medicines Agency
'Truly Unique' Four-Agency Work-Sharing Pilot Aims To Cut Regulatory Burden & Speed Decisions
'Truly Unique' Four-Agency Work-Sharing Pilot Aims To Cut Regulatory Burden & Speed Decisions
Plans For East African Drug Regulator Begin To Take Shape
Could The EMA Be A Regulatory Model For East Africa?
New ICH Guideline Could Hold The Key To Better Global Management Of Product Variations
EMA Review Of Non-EU Drugs To Be Made More Useful For African Regulators
Janssen Pilot Speeds Up African Approvals As Harmonization Project Expands

Topics

Advertisement
UsernamePublicRestriction

Register

PS119932

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel